FASTER

FASTER PROCESS

Our complete development solution gives you 2 μmol of material in 4-6 weeks from receipt of target.
rdg1

SELECTION

Raptamer Discovery Group uses our innovative, non-SELEX process, which has been developed and refined over the past two decades by leaders in the aptamer field. We conduct a fast, single-round selection against your targets using our proprietary library.

rdg2

SEQUENCING

Raptamer Discovery Group uses next-generation sequencing technology to identify the nucleotide sequencing in each Raptamer™ candidate, and we use this information and our library data to identify the complete chemical structure, including side chains.

rdg3

ANALYSIS

Using our sophisticated bioinformatics platform, we rank Raptamer™ candidates by their predicted performance. We have a good sense of candidate quality at this point, and will give you feedback on how the process is going.

rdg4

SMALL-SCALE SYNTHESIS

We synthesize the highest-ranked Raptamer™ candidates for each target at a 50 nanomol scale for use in our internal binding studies.

rdg5

BINDING STUDY

We test each of the Raptamer™ candidates for binding against your target using the sophisticate, ForteBio Octet Red biomolecular interaction platform. We share these results with you to decide which candidates you want made at a medium scale.

Asset 16

MEDIUM-SCALE SYNTHESIS

We synthesize up to 4 candidates at 2 μmol scale, and prepare vials for shipping to you for use in the next steps of your development process.

Raptamers™

NEXT-GENERATION APTAMERS

FASTER

4-6 Weeks from Target Receipt to Material Shipped

STRONGER

Higher Affinity Binding
null

BETTER

Extensive Modifications Available

No PCR Bias

Raptamer Discovery Group’s mission is to help you find great binding molecules for your research or commercial application. Faster, stronger, better: the Raptamer™ way!

Let’s Discover a Raptamer™ Together!